Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01258335 · ClinicalTrials.gov registry record · NA
Omega-3-fatty Acids on Age-related Macular
A NA study of Aged Macular Degeneration, sponsored by Mid Atlantic Retina.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT01258335 is a NA study of Aged Macular Degeneration that has completed, run by Mid Atlantic Retina. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01258335, a NA study of Aged Macular Degeneration, has completed, sponsored by Mid Atlantic Retina.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Aim: To demonstrate the short-term multi focal electroretinogram (mfERG) effect of oral omega-3-fatty acids in the triglyceride form on dry age-related macular degeneration (AMD). Null hypothesis: Omega-3-fatty acids do not affect the mfERGs of patients with dry AMD.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Omega 3
- OTHER Olive Oil
Study Locations (1)
Pennsylvania
- Mid Atlantic Retina - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01258335
The ClinicalTrials.gov registry entry for NCT01258335 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mid Atlantic Retina, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aged Macular Degeneration appearing as the primary indexed condition, and to 2 interventions - of which Omega 3 is the first listed.
NCT01258335 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01258335 about?
NCT01258335 is a clinical study titled "Omega-3-fatty Acids on Age-related Macular". Aim: To demonstrate the short-term multi focal electroretinogram (mfERG) effect of oral omega-3-fatty acids in the triglyceride form on dry age-related macular degeneration (AMD). Null hypothesis: Omega-3-fatty acids do not affect the mfERGs of patients with dry AMD.
What is the current status of trial NCT01258335?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2008-10. Estimated completion is 2010-11.
What conditions does trial NCT01258335 study?
This clinical trial studies the following conditions: Aged Macular Degeneration.
What interventions are being tested in trial NCT01258335?
The interventions under investigation include: Omega 3 (DIETARY_SUPPLEMENT), Olive Oil (OTHER).
Who is sponsoring clinical trial NCT01258335?
This trial is sponsored by Mid Atlantic Retina, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01258335 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.